Volume Spike Investor

Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) managed to post an unexpected profit of $2.2 million for its last quarter.  Shares of the neurology and psychiatry pharmaceutical company rose by more than 10% in the post-earnings reaction and are doing even better this morning.  As of 8:22 AM EST we have seen 154,000 trade hands versus 2.5 million on average and the 19% gain has shares at $7.79.  Be advised that this traded 1.19 million shares after the report last night, so that average volume may be hit between pre-market and after-hours activity this morning.  The 52-week high is $8.85. -JON OGG